A Future With Rapamycin – the Researches of the Famous Oncologist Mikhail Blagosklonny
Mikhail Blagosklonny has an unrivaled role in the race against aging and in the field of medical research. Rosewell Park Cancer Institute accommodates this professor of Oncology who has carried out numerous investigations on cancer and its therapies, and also aging. He advocates Rapamycin is a cancer drug, for increasing the lifespan of humans. Rapamycin, or Sirolimus as it’s also called (it is, however, known has Rapamune in the pharmacy market), is a drug that can be used in preventing rejection of organ transplant. It has more uses, but majorly famous as a cancer drug.
However, before we talk about Mikhail Blagosklonny in detail, let’s get to know about the drug, Rapamycin, he strongly advocates for aging. Why is Rapamycin so delicate to cancer and aging? Some of the reasons why it is one of the best drugs available now is because of its immunosuppressant properties (i.e., a drug that helps for successful transplant of an organ) combined with its low toxic level towards the kidney; it is also valuable for coating of the coronary stents in order to prevent restenosis in the arteries after a balloon angioplasty procedure. The drug is invaluable in the treatment of cancer, Tuberous Sclerosis Complex (a congenital disorder able to cause tumor growth in the brain, kidneys, etc.), Facial angiofibromas (rash/spots mostly found on the nose and also cheeks of Tuberous Sclerosis Complex sufferer); and to increase longevity, this is where Mikhail Blagosklonny’s name pops up always. Mikhail Blagklosklonny is well-known for his work on what he named the anti-aging drug of the future, where he is utilizing the regenerative effects of Rapamycin to treat diseases that come with aging and possibly even extend the lifespan of humans.
Mikhail Blagosklonny is a professor, researcher, philanthropist and famously involved in keeping up alive and ensuring people around the world get access to the best treatment regardless of their financial standing. He concerns himself specifically with cancer and aging, and finding the connection that exists between the two. The topics that Mikhail has picked to research on are of much interest to the medical field. His goal is to find an effective and efficient way to treat cancer that would involve less pain and expenses as the current treatments. He’s bent on finding out a way to eliminate cancerous cells from the body without destroying the normal cells in the body of the patient.
A lot of progress has already been made in his study, and this has created more areas for other researchers to explore. He’s influential and pivotal to the medical field; he serves as an inspiration to his students and his colleagues in the medical area who hope to further his research on cancer treatment and saving humankind from aging.
The anti-aging drug is a research that is still under development, and it is already showing great promises, as it has been featured in countless articles and newsletters about medicine as one of the most essential researches in Oncology. One thing is for sure: Mikhail has already changed medication forever with his work.